Clinical features and genetic biomarkers associated with different phenotypes of systemic lupus erythematosus in Paraguayan patients.

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by a heterogeneous clinical picture that makes the diagnosis and follow-up of these patients difficult. This study aimed to identify correlations between clinical, immunological, and genetic biomarkers and clinical manifestations in SLE. A retrospective study of data from medical records and immunological and genetic studies of SLE patients in Paraguay was carried out. A descriptive analysis was performed based on the type of variable. Human leukocyte antigen (HLA) allele frequencies (DPA1, DPB1, DQA1, DQB1, and DRB1) were calculated, and univariate logistic regression analyses were performed between each of the explanatory variables and the presence or absence of each phenotype. Odds ratios, 95% confidence intervals, and p values were recorded. Associations with p<0.05 were considered statistically significant. 104 SLE patients were included: 86% were female, with a mean age of 32.80±10.36 years. An association was identified between anti-double stranded DNA (anti-dsDNA) and the presence of the renal phenotype and between anti-dsDNA and the absence of the joint and hematological phenotypes. Immunoglobulin M isotype rheumatoid factor was associated with the absence of a renal phenotype. HLA-DQB1*02:02 and HLA-DRB1*07:01 were associated with the cutaneous phenotype. An association was identified between age at disease onset over 30 years and the presence of the joint phenotype. No other associations were identified. Potential clinical, immunological, and genetic biomarkers of phenotypes have been identified in SLE Paraguayan patients.

Medicina regenerativa y enfermedades cardiovasculares: Terapiacon células madre / Regenerative medicine and cardiovascular diseases: stem cell therapy

La medicina regenerativa es un campo interdisciplinario emergente, que busca reparar,reemplazar y regenerar células, tejidos y órganos, con la finalidad de restaurar la perdida de sufunción. Las enfermedades cardiovasculares son una de las principales causas de muerte en elmundo y la posibilidad de regeneración cardiaca vía terapia celular con células madre hadespertado gran interés en la medicina actual. El propósito de este artículo es presentar unabreve descripción de las aplicaciones de las células madre en la medicina cardiovascular yresumir los actuales avances clínicos en este campo